Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
EMBC Embecta Corp delivers Q1 2026 earnings above expectations shares climb as investors overlook mild yearly revenue declines MSTR Strategy Inc climbs 118 percent on positive investor sentiment despite steep Q4 2025 earnings miss Solid Power SLDP Stock Investment Season Edges Up 20260418 Market Moves Tech leads sector gains as consumer stocks lag in muted mixed trading Does Tenaya Therapeutics TNYA stock carry significant risk Q4 2025 Better Than Expected Landmark Bancorp LARK Stock Counter Trend 031 20260420 Lunar Communications Infrastructure Development and CrossSector Commercial Opportunities European Income Tax Rates Vary Widely Children Offer Significant Relief in Several Nations PIMCO PFN Slides 144 as Selling Pressure Mounts 20260515 Cerebras Shares Decline 10 on First Full Trading Day Following Strong IPO Debut ACM Awards 2026 Nominees Announced as Country Musics Biggest Night Approaches Borealis BRLS Stock Analysis 217 Gain What to Watch 20260518 Dogness DOGZ Drops 508 Key Support at 106 20260518 Dating Startups Target Trust New Apps Aim to Eliminate Fake Profiles in Online Dating SAP Unveils Vision for Next Era of Business AI US April Payrolls Surge Above Expectations Yet Underlying Economic Concerns Emerge Airtel Defends Priority Postpaid Plan Before DoT Denies Net Neutrality Breach Biotech ETFs for 2026 Market Outlook and Investment Considerations SK Hynix Surpasses 1 Trillion Market Cap as AI Rally Powers South Korean Chip Stocks SLQT Q1 2026 Earnings Significant EPS Beat Driven by Operational Efficiency QBTS Q1 2026 Earnings Narrowed Loss Beats Estimates Shares Surge TRIN Q1 2026 Earnings Slight EPS Beat Amidst Stock Decline IRTC Q1 2026 Earnings Widerthanexpected Loss Narrows Stock Rises 379 Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending Rocket Pharmaceuticals Inc RCKT Q1 2026 Earnings Clinical Progress Overshadowed by Slight EPS Miss and Capital Concerns Beazer Homes BZH Rises 2 on Sector Strength Key Resistance in Focus Greif Inc GEF Holds Steady Near Support as Market Awaits Direction Philip Morris International PM Holds Steady Near 189 as Traders Eye Resistance Levels ITT Inc ITT Surges 3 Breaking Out Toward Resistance Amid Strong Momentum Purple Biotech PPBT Edges Higher Modest Uptick Faces Resistance at 304